{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T03:13:24Z","timestamp":1793157204847,"version":"4.5.0"},"reference-count":63,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,6]]},"abstract":"<jats:sec>\n                    <jats:title>Purpose of review<\/jats:title>\n                    <jats:p>This review will describe pulmonary complications of hematopoietic stem cell transplantation (HCT) are a significant source of short- and long-term morbidity and mortality. In recent years the amount of HCT being performed in pediatric continues to increase with new disease included as a form of treatment. Complications which include infection, inflammation, immune mediated damage, and regimen associated toxicity is critically import for early recognition to avoid end organ damage.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Recent findings<\/jats:title>\n                    <jats:p>This review encompasses current literature related to pediatric pulmonary complications of HCT. Types of HCT and conditioning treatments have changed over the past 15\u201320\u200ayears with the goal of reducing complications of HCT such as graft versus host disease. Updated guidelines will be referenced that address post HCT follow up recommendations in pediatrics.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Summary<\/jats:title>\n                    <jats:p>Timely diagnosis of post HCT complications will improve overall care. Ongoing research in this field is needed to continue to improve outcomes and identify biomarkers of disease. Large cohort prospective studies are needed and underway to improve our knowledge with the goal of narrowing the knowledge gap in this field.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/mop.0000000000001571","type":"journal-article","created":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T14:00:37Z","timestamp":1776261637000},"page":"286-292","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Pulmonary complications in pediatric hematopoietic stem cell transplantation: an overview for pediatricians"],"prefix":"10.1097","volume":"38","author":[{"given":"Meera A.","family":"Srikanthan","sequence":"first","affiliation":[{"name":"Division of Pediatric Blood and Marrow Transplantation and Cellular Therapy, University of Minnesota, Minneapolis, Minnesota"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pi Chun","family":"Cheng","sequence":"additional","affiliation":[{"name":"Division of Pediatric Pulmonology, Allergy, and Sleep Medicine, Riley Hospital for Children, Indiana University, Bloomington, Indiana"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel B.","family":"Goldfarb","sequence":"additional","affiliation":[{"name":"Division of Pediatric Pulmonology and Sleep Medicine, University of Minnesota, Minneapolis, Minnesota, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,4,15]]},"reference":[{"key":"R1-20260512","doi-asserted-by":"crossref","first-page":"755878","DOI":"10.3389\/fonc.2021.755878","article-title":"Pulmonary complications after pediatric stem cell transplant","volume":"11","author":"Fitch","year":"2021","journal-title":"Front Oncol"},{"key":"R2-20260512","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1513\/AnnalsATS.202001-006OT","article-title":"Pulmonary complications of pediatric hematopoietic cell transplantation. a national institutes of health workshop summary","volume":"18","author":"Tamburro","year":"2021","journal-title":"Ann Am Thorac Soc"},{"key":"R3-20260512","doi-asserted-by":"crossref","first-page":"e70002","DOI":"10.1002\/cti2.70002","article-title":"Biomarkers to predict and diagnose pulmonary complications in children post haematopoietic stem cell transplant","volume":"13","author":"Walker","year":"2024","journal-title":"Clin Transl Immunol"},{"key":"R4-20260512","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.1016\/j.bbmt.2019.06.004","article-title":"Pulmonary complications in pediatric and adolescent patients following allogeneic hematopoietic cell transplantation","volume":"25","author":"Broglie","year":"2019","journal-title":"Biol Blood Marrow Transplant"},{"key":"R5-20260512","first-page":"259","article-title":"Major pulmonary complications after hematopoietic stem cell transplant","volume":"14","author":"Diab","year":"2016","journal-title":"Exp Clin Transplant"},{"key":"R6-20260512","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1164\/rccm.2007-413ST","article-title":"An official American Thoracic Society research statement: noninfectious lung injury after hematopoietic stem cell transplantation: idiopathic pneumonia syndrome","volume":"183","author":"Panoskaltsis-Mortari","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"key":"R7-20260512","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.jtct.2022.03.015","article-title":"Noninfectious pulmonary toxicity after allogeneic hematopoietic cell transplantation","volume":"28","author":"Patel","year":"2022","journal-title":"Transplant Cell Ther"},{"key":"R8-20260512","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.ccm.2016.12.007","article-title":"Early onset noninfectious pulmonary syndromes after hematopoietic cell transplantation","volume":"38","author":"Vande Vusse","year":"2017","journal-title":"Clin Chest Med"},{"key":"R9-20260512","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1164\/rccm.201712-2456OC","article-title":"Lung dysbiosis, inflammation, and injury in hematopoietic cell transplantation","volume":"198","author":"O\u2019Dwyer","year":"2018","journal-title":"Am J Respir Crit Care Med"},{"key":"R10-20260512","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1002\/pbc.23298","article-title":"Incidence, clinical features, and risk factors of idiopathic pneumonia syndrome following hematopoietic stem cell transplantation in children","volume":"58","author":"Sakaguchi","year":"2012","journal-title":"Pediatr Blood Cancer"},{"key":"R11-20260512","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/bmt.2013.123","article-title":"Risk factor analysis of idiopathic pneumonia syndrome after allogeneic hematopoietic SCT in children","volume":"49","author":"Sano","year":"2014","journal-title":"Bone Marrow Transplant"},{"key":"R12-20260512","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1080\/10428194.2022.2057486","article-title":"Risk factors and outcomes of definite or clinical idiopathic pneumonia syndrome after allogeneic hematopoietic stem cell transplantation","volume":"63","author":"Tamaki","year":"2022","journal-title":"Leuk Lymphoma"},{"key":"R13-20260512","doi-asserted-by":"crossref","first-page":"2777","DOI":"10.1182\/blood-2003-05-1597","article-title":"Risks and outcomes of idiopathic pneumonia syndrome after nonmyeloablative and conventional conditioning regimens for allogeneic hematopoietic stem cell transplantation","volume":"102","author":"Fukuda","year":"2003","journal-title":"Blood"},{"key":"R14-20260512","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1016\/j.bbmt.2017.07.019","article-title":"Etanercept and corticosteroid therapy for the treatment of late-onset idiopathic pneumonia syndrome","volume":"23","author":"Thompson","year":"2017","journal-title":"Biol Blood Marrow Transplant"},{"key":"R15-20260512","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1038\/bmt.2011.260","article-title":"High-dose corticosteroids with or without etanercept for the treatment of idiopathic pneumonia syndrome after allo-SCT","volume":"47","author":"Tizon","year":"2012","journal-title":"Bone Marrow Transplant"},{"key":"R16-20260512","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.bbmt.2014.09.019","article-title":"TNF-receptor inhibitor therapy for the treatment of children with idiopathic pneumonia syndrome. A joint Pediatric Blood and Marrow Transplant Consortium and Children's Oncology Group Study (ASCT0521)","volume":"21","author":"Yanik","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"key":"R17-20260512","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1016\/j.bbmt.2014.02.026","article-title":"Randomized, double-blind, placebo-controlled trial of soluble tumor necrosis factor receptor: enbrel (etanercept) for the treatment of idiopathic pneumonia syndrome after allogeneic stem cell transplantation: blood and marrow transplant clinical trials network protocol","volume":"20","author":"Yanik","year":"2014","journal-title":"Biol Blood Marrow Transplant"},{"key":"R18-20260512","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S1658-3876(10)50025-6","article-title":"The spectrum of noninfectious pulmonary complications following hematopoietic stem cell transplantation","volume":"3","author":"Soubani","year":"2010","journal-title":"Hematol Oncol Stem Cell Ther"},{"key":"R19-20260512","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1038\/s41409-022-01859-4","article-title":"Interstitial lung diseases after hematopoietic stem cell transplantation: new pattern of lung chronic graft-versus-host disease?","volume":"58","author":"Archer","year":"2023","journal-title":"Bone Marrow Transplant"},{"key":"R20-20260512","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1177\/10935266231170101","article-title":"Pulmonary histopathologic findings in pediatric patients after hematopoietic stem cell transplantation: an autopsy study","volume":"26","author":"Cortes-Santiago","year":"2023","journal-title":"Pediatr Dev Pathol"},{"key":"R21-20260512","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1111\/his.13697","article-title":"Lung histopathology of noninfectious pulmonary complications after allogeneic haematopoietic stem cell transplantation","volume":"73","author":"Meignin","year":"2018","journal-title":"Histopathology"},{"key":"R22-20260512","doi-asserted-by":"crossref","first-page":"400","DOI":"10.5152\/dir.2016.15516","article-title":"Pleuroparenchymal fibroelastosis: the prevalence of secondary forms in hematopoietic stem cell and lung transplantation recipients","volume":"22","author":"Mariani","year":"2016","journal-title":"Diagn Interv Radiol"},{"key":"R23-20260512","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1183\/09031936.00214713","article-title":"Pleuroparenchymal fibroelastosis as a late complication of chemotherapy agents","volume":"44","author":"Beynat-Mouterde","year":"2014","journal-title":"Eur Respir J"},{"key":"R24-20260512","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.resinv.2019.04.003","article-title":"Cause of pleuroparenchymal fibroelastosis following allogeneic hematopoietic stem cell transplantation","volume":"57","author":"Higo","year":"2019","journal-title":"Respir Investig"},{"key":"R25-20260512","doi-asserted-by":"crossref","first-page":"2266","DOI":"10.1007\/s00330-022-09188-2","article-title":"Pleuroparenchymal fibroelastosis after hematopoietic stem cell transplantation in children: a propensity score-matched analysis","volume":"33","author":"Oh","year":"2023","journal-title":"Eur Radiol"},{"key":"R26-20260512","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1513\/AnnalsATS.201902-181CME","article-title":"Pleuroparenchymal fibroelastosis a review of clinical, radiological, and pathological characteristics","volume":"16","author":"Chua","year":"2019","journal-title":"Ann Am Thorac Soc"},{"key":"R27-20260512","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1183\/23120541.00529-2023","article-title":"Real-world experience of nintedanib for progressive fibrosing interstitial lung disease in the UK","volume":"10","author":"Dixon","year":"2024","journal-title":"ERJ Open Res"},{"key":"R28-20260512","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.resinv.2024.12.009","article-title":"Idiopathic pleuroparenchymal fibroelastosis: a review of the previous literature and current knowledge","volume":"63","author":"Suzuki","year":"2025","journal-title":"Respir Investig"},{"key":"R29-20260512","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1186\/s13023-021-02043-5","article-title":"Nintedanib in idiopathic and secondary pleuroparenchymal fibroelastosis","volume":"16","author":"Nasser","year":"2021","journal-title":"Orphanet J Rare Dis"},{"key":"R30-20260512","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0272-5231(03)00123-0","article-title":"Chemotherapy-induced lung disease","volume":"25","author":"Limper","year":"2004","journal-title":"Clin Chest Med"},{"key":"R31-20260512","first-page":"63","article-title":"Pulmonary complications of childhood cancer treatment","volume":"17","author":"Versluys","year":"2016","journal-title":"Paediatr Respir Rev"},{"key":"R32-20260512","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.radonc.2017.09.026","article-title":"Lung toxicity after radiation in childhood: Results of the international project on prospective analysis of radiotoxicity in childhood and adolescence","volume":"125","author":"Stoppel","year":"2017","journal-title":"Radiother Oncol"},{"key":"R33-20260512","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.jtct.2022.11.012","article-title":"Noninfectious pulmonary complications after hematopoietic stem cell transplantation","volume":"29","author":"Fraebel","year":"2023","journal-title":"Transplant Cell Ther"},{"key":"R34-20260512","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1001\/jama.2009.1018","article-title":"Bronchiolitis obliterans after allogeneic hematopoietic stem cell transplantation","volume":"302","author":"Williams","year":"2009","journal-title":"JAMA"},{"key":"R35-20260512","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/j.jtct.2024.05.012","article-title":"Diagnosis of post-hematopoietic stem cell transplantation bronchiolitis obliterans syndrome in children: time for a rethink?","volume":"30","author":"Shanthikumar","year":"2024","journal-title":"Transplant Cell Ther"},{"key":"R36-20260512","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1164\/rccm.202406-1117ST","article-title":"Detection of bronchiolitis obliterans syndrome after pediatric hematopoietic stem cell transplantation: an official American Thoracic Society Clinical Practice Guideline","volume":"210","author":"Shanthikumar","year":"2024","journal-title":"Am J Respir Crit Care Med"},{"key":"R37-20260512","doi-asserted-by":"crossref","first-page":"240043","DOI":"10.1183\/20734735.0043-2024","article-title":"Pulmonary complications of bone marrow transplantation","volume":"20","author":"O\u2019Brien","year":"2024","journal-title":"Breathe (Sheff)"},{"key":"R38-20260512","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1182\/bloodadvances.2020003455","article-title":"A pragmatic multiinstitutional approach to understanding transplant-associated thrombotic microangiopathy after stem cell transplant","volume":"5","author":"Dandoy","year":"2021","journal-title":"Blood Adv"},{"key":"R39-20260512","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1053\/j.seminhematol.2018.04.003","article-title":"Complement in pathophysiology and treatment of transplant-associated thrombotic microangiopathies","volume":"55","author":"Jodele","year":"2018","journal-title":"Semin Hematol"},{"key":"R40-20260512","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1513\/AnnalsATS.202008-1032OC","article-title":"Characteristics and outcome of periengraftment respiratory distress syndrome after autologous hematopoietic cell transplant","volume":"18","author":"Wieruszewski","year":"2021","journal-title":"Ann Am Thorac Soc"},{"key":"R41-20260512","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1182\/blood-2014-03-564997","article-title":"Diagnostic and risk criteria for HSCT-associated thrombotic microangiopathy: a study in children and young adults","volume":"124","author":"Jodele","year":"2014","journal-title":"Blood"},{"key":"R42-20260512","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.bbmt.2012.08.022","article-title":"Pulmonary arterial hypertension in pediatric patients with hematopoietic stem cell transplant-associated thrombotic microangiopathy","volume":"19","author":"Jodele","year":"2013","journal-title":"Biol Blood Marrow Transplant"},{"key":"R43-20260512","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1002\/ajh.70044","article-title":"Narsoplimab results in excellent survival in adults and children with hematopoietic cell transplant associated thrombotic microangiopathy (TA-TMA)","volume":"100","author":"Schoettler","year":"2025","journal-title":"Am J Hematol"},{"key":"R44-20260512","doi-asserted-by":"crossref","first-page":"45 e1","DOI":"10.1016\/j.jtct.2022.09.026","article-title":"Pulmonary manifestations and vascular changes in pediatric transplantation-associated thrombotic microangiopathy","volume":"29","author":"Schoettler","year":"2023","journal-title":"Transplant Cell Ther"},{"key":"R45-20260512","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1177\/08850666231207331","article-title":"Diffuse alveolar hemorrhage in hematopoietic cell transplantation","volume":"39","author":"Lynch","year":"2024","journal-title":"J Intensive Care Med"},{"key":"R46-20260512","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1038\/s41409-022-01644-3","article-title":"Diffuse alveolar hemorrhage: an underreported complication of transplant associated thrombotic microangiopathy","volume":"57","author":"Agarwal","year":"2022","journal-title":"Bone Marrow Transplant"},{"key":"R47-20260512","doi-asserted-by":"crossref","first-page":"1017 e1","DOI":"10.1016\/j.jtct.2024.07.022","article-title":"Epidemiology of diffuse alveolar hemorrhage in pediatric allogeneic hematopoietic cell transplantation recipients","volume":"30","author":"Cheng","year":"2024","journal-title":"Transplant Cell Ther"},{"key":"R48-20260512","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1038\/sj.bmt.1705990","article-title":"Pulmonary veno-occlusive disease following hematopoietic stem cell transplantation: a rare model of endothelial dysfunction","volume":"41","author":"Bunte","year":"2008","journal-title":"Bone Marrow Transplant"},{"key":"R49-20260512","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1016\/j.ajpath.2019.02.007","article-title":"Understanding the similarities and differences between hepatic and pulmonary veno-occlusive disease","volume":"189","author":"Gunther","year":"2019","journal-title":"Am J Pathol"},{"key":"R50-20260512","first-page":"338","article-title":"Pulmonary veno-occlusive disease after autologous stem cell transplantation","volume":"16","author":"Hamada","year":"2023","journal-title":"Case Rep Oncol"},{"key":"R51-20260512","doi-asserted-by":"crossref","first-page":"160 e1","DOI":"10.1016\/j.jtct.2021.12.006","article-title":"Incidence and outcomes of respiratory failure after nonmyeloablative related haploidentical blood or marrow transplantation","volume":"28","author":"Stephens","year":"2022","journal-title":"Transplant Cell Ther"},{"key":"R52-20260512","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.cll.2018.10.005","article-title":"Biomarkers for early complications after hematopoietic stem cell transplantation","volume":"39","author":"Rowan","year":"2019","journal-title":"Clin Lab Med"},{"key":"R53-20260512","doi-asserted-by":"crossref","first-page":"634449","DOI":"10.3389\/fped.2021.634449","article-title":"A review of infections after hematopoietic cell transplantation requiring PICU care: transplant timeline is key","volume":"9","author":"Ferdjallah","year":"2021","journal-title":"Front Pediatr"},{"key":"R54-20260512","doi-asserted-by":"crossref","first-page":"668.e1","DOI":"10.1016\/j.jtct.2025.06.020","article-title":"Inflammatory markers and microbiome dysbiosis in hematopoietic cell transplant recipients with lung graft-versus-host disease","volume":"31","author":"Brehm","year":"2025","journal-title":"Transplant Cell Ther"},{"key":"R55-20260512","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/j.bbmt.2017.11.039","article-title":"Diagnostic and prognostic plasma biomarkers for idiopathic pneumonia syndrome after hematopoietic cell transplantation","volume":"24","author":"Seo","year":"2018","journal-title":"Biol Blood Marrow Transplant"},{"key":"R56-20260512","doi-asserted-by":"crossref","first-page":"106493","DOI":"10.1016\/j.rmed.2021.106493","article-title":"Major pulmonary complications following hematopoietic stem cell transplantation: what the pulmonologist needs to know","volume":"185","author":"Shiari","year":"2021","journal-title":"Respir Med"},{"key":"R57-20260512","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1038\/s41591-024-02999-4","article-title":"Pathobiological signatures of dysbiotic lung injury in pediatric patients undergoing stem cell transplantation","volume":"30","author":"Zinter","year":"2024","journal-title":"Nat Med"},{"key":"R58-20260512","doi-asserted-by":"crossref","first-page":"S137","DOI":"10.1016\/j.jtct.2024.01.032","article-title":"Towards early detection of post-allogeneic bone marrow transplant bronchiolitis obliterans syndrome (BOS) \u2013 the use of portable airway oscillometry","volume":"30","author":"Cook","year":"2024","journal-title":"Transplant Cell Ther"},{"key":"R59-20260512","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1182\/blood.2020009246","article-title":"The pulmonary metatranscriptome prior to pediatric HCT identifies post-HCT lung injury","volume":"137","author":"Zinter","year":"2021","journal-title":"Blood"},{"key":"R60-20260512","doi-asserted-by":"crossref","first-page":"eabm8646","DOI":"10.1126\/scitranslmed.abm8646","article-title":"Pulmonary microbiome and gene expression signatures differentiate lung function in pediatric hematopoietic cell transplant candidates","volume":"14","author":"Zinter","year":"2022","journal-title":"Sci Transl Med"},{"key":"R61-20260512","doi-asserted-by":"crossref","first-page":"S120","DOI":"10.1016\/j.jtct.2024.01.020","article-title":"Measurement of respiratory system function by airwave oscillometry (AOS) in a cohort of children undergoing hematopoietic stem cell transplant (HSCT)","volume":"30","author":"Josephson","year":"2024","journal-title":"Transplant Cell Ther"},{"key":"R62-20260512","doi-asserted-by":"crossref","first-page":"328 e1","DOI":"10.1016\/j.jtct.2022.02.002","article-title":"Multiple breath washout testing to identify pulmonary chronic graft versus host disease in children after hematopoietic stem cell transplantation","volume":"28","author":"Rayment","year":"2022","journal-title":"Transplant Cell Ther"},{"key":"R63-20260512","doi-asserted-by":"crossref","first-page":"220251","DOI":"10.1183\/16000617.0251-2022","article-title":"Multiple breath washout and oscillometry after allogenic HSCT: a scoping review","volume":"32","author":"Sonneveld","year":"2023","journal-title":"Eur Respir Rev"}],"container-title":["Current Opinion in Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MOP.0000000000001571","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T08:01:28Z","timestamp":1778572888000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MOP.0000000000001571"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,15]]},"references-count":63,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/mop.0000000000001571","relation":{},"ISSN":["1531-698X"],"issn-type":[{"value":"1531-698X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,15]]}}}